Robert Andrew Douglas - 15 Feb 2022 Form 4 Insider Report for RESMED INC (RMD)

Role
President and COO
Signature
Robert Douglas, President and Chief Operating Officer, ResMed Inc.
Issuer symbol
RMD
Transactions as of
15 Feb 2022
Net transactions value
-$1,420,560
Form type
4
Filing time
16 Feb 2022, 15:08:17 UTC
Previous filing
31 Jan 2022
Next filing
16 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Options Exercise $465,920 +8,000 +47% $58.24 25,175 15 Feb 2022 Direct F1
transaction RMD ResMed Common Stock Sale $1,886,480 -8,000 -32% $235.81 17,175 15 Feb 2022 Direct F1
holding RMD ResMed Common Stock 234,995 15 Feb 2022 Douglas Family Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMD ResMed Common Stock Options Options Exercise $0 -8,000 -10% $0.000000 70,098 15 Feb 2022 ResMed Common Stock 8,000 $58.24 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 Represents date options first became exercisable. Options vest 1/3 per year.